![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Pharmacia & Upjohn Company Kalamazoo Us, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Methylprednisolone, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2000-361 - Rev 00
This TSE Type CEP, issued on October 24, 2001, remains in force until October 24, 2006, ensuring its reliability within the pharmaceutical industry.
Substance Number 561 associated with this CEP further emphasizes